Topics

No keywords indexed for this article. Browse by subject →

References
18
[1]
Schistosomiasis: key facts. Geneva: World Health Organization April 17 2019 (https://www.who.int/news-room/fact-sheets/detail/schistosomiasis).
[4]
Schistosomiasis. Geneva: World Health Organization 2018 (https://www.who.int/schistosomiasis/en/).
[5]
Hotez PJ. Forgotten people forgotten diseases: the neglected tropical diseases and their impact on global health and development. Emerg Infect Dis 2009;15:510-5101. 10.3201/eid1503.081597
[7]
Genital manifestations of schistosomiasis. Geneva: World Health Organization 2018 (https://www.who.int/schistosomiasis/genital_schistosomiasis/en/).
[9]
Helminth control in school age children: a guide for managers of control programmes. 2nd ed. Geneva: World Health Organization 2011.
[11]
Progress report 2001–2011 and strategic plan 2012–2020. Geneva: World Health Organization 2013.
[13]
Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Geneva: World Health Organization 2012.
[14]
Toor J, Alsallaq R, Truscott JE, et al. Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current World Health Organization guidelines? Clin Infect Dis 2018;66:Suppl 4:S245-S252.29860290 10.1093/cid/ciy001
[17]
Crellen T, Walker M, Lamberton PH, et al. Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration. Clin Infect Dis 2016;63:1151-1159.27470241
Metrics
170
Citations
18
References
Details
Published
Dec 26, 2019
Vol/Issue
381(26)
Pages
2519-2528
License
View
Authors
Cite This Article
Arminder K. Deol, Fiona M. Fleming, Beatriz Calvo-Urbano, et al. (2019). Schistosomiasis — Assessing Progress toward the 2020 and 2025 Global Goals. New England Journal of Medicine, 381(26), 2519-2528. https://doi.org/10.1056/nejmoa1812165